Two Phase III clinical trials on corifollitropin alfa (Org 36286) reach randomization target
... areas of anesthesia. It hasextensive expertise in neuroscience and a rich and focused R&Dprogram. Research areas also include immunology and specific areasof oncology. Organon products are distributed in over 100 countriesworldwide, of which more than 50 have an Organon subsidiary.Organon is the human health...... areas of anesthesia. It hasextensive expertise in neuroscience and a rich and focused R&Dprogram. Research areas also include immunology and specific areasof oncology. Organon products are distributed in over 100 countriesworldwide, of which more than 50 have an Organon subsidiary.Organon is the human health...... areas of anesthesia. It hasextensive expertise in neuroscience and a rich and focused R&Dprogram. Research areas also include immunology and specific areasof oncology. Organon products are distributed in over 100 countriesworldwide, of which more than 50 have an Organon subsidiary.Organon is the human health......ssociated withmenopause. Wyeth is a leader in both neuroscience and women'shealth care. Wyeth discovered and developed the first SNRI approved by theFDA, which currently is the most widely used antidepressant in theworld. Desvenlafaxine represents Wyeth's latest efforts andcontinued commitment to developing ther...... areas of anesthesia. It hasextensive expertise in neuroscience and a rich and focused R&Dprogram. Research areas also include immunology and specific areasof oncology. Organon products are distributed in over 100 countriesworldwide, of which more than 50 have an Organon subsidiary.Organon is the human health......ssociated withmenopause. Wyeth is a leader in both neuroscience and women'shealth care. Wyeth discovered and developed the first SNRI approved by theFDA, which currently is the most widely used antidepressant in theworld. Desvenlafaxine represents Wyeth's latest efforts andcontinued commitment to developing ther...Data to be presented at AAN Meeting -Study results of drug candidate for MS
...care solutions. Novartis has been a leader in the neuroscience area for morethan 50 years, having pioneered early breakthrough treatments forAlzheimer's disease, Parkinson's disease, Attention DeficitHyperactivity Disorder, epilepsy, schizophrenia and migraine, manyof which continue to be regarded as "gold stand......ing to explore theutility of CB1 antagonist in the neuroscience field. About La Merie La Merie S.L. is a Business Intelligence enterprise fullydedicated to provide high quality R&D information to thebiopharmaceutical industry. La Merie offers individual consultancyservices and publishes reports and periodic...